Huma

Huma

Private
London, EnglandHealthcare & Life Scienceshttps://www.huma.com

Last Round

Early Funding

9/13/2024

Total Funding Raised

$372M

Company Overview

Huma (Other Healthcare Technology Systems) is a healthcare technology company that offers a remote patient monitoring platform aimed at enhancing connected care and accelerating research through the integration of predictive algorithms, digital biomarkers, and real-world data.

Sector

Healthcare & Life Sciences

Verticals

Platform-as-a-Service, Clinical Trials, Telemedicine, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMdecentralized clinical trialsDCTdigital health platformhospital-at-homevirtual wardshealthcare PaaSSoftware as a Medical DeviceSaMDregulated platformAI clinical documentationAI scribevirtual care platformclinical trial technologyreal-world evidencepatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Huma Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Huma Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early Funding9/13/2024
Series D7/16/2024
Series C5/11/2021
M&A4/16/2020
Series B11/5/2019
Series A
2/2/2018

Key People

Founding team and executive leadership

Ali Omrani

Field CEO

Executive Team

Dan Vahdat

CEO Founder

Founding Team

Justine T.

Field CEO, GDm-Health

Executive Team

Shahrzad Pakgohar

Deputy Field CEO

Executive Team

Huma Investors

Notable investors and investment history

InvestorRounds
Stellar Development FoundationEarly Funding
Dale VenturesSeed
Leaps by BayerSeries D
NWS HoldingsSeries B, Series A
Distributed GlobalEarly Funding
Samsung NEXT VenturesSeries C
Hitachi VenturesSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Launched Hi Scribe, a generative AI clinical documentation tool.

  • May 19, 2025

    Acquired Aluna to expand US presence.

Huma Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Huma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Huma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon, England
Employee Range270
Year Founded2011
Last Funding9/13/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.